Summary
The variation in the risk of solid second malignant neoplasms (SMN) with time since first cancer during childhood has been previously reported. However, no study has been performed that controls for the distribution of radiation dose and the aggressiveness of past chemotherapy, which could be responsible for the observed temporal variation of the risk. The purpose of this study was to investigate the influence of the treatment on the long-term pattern of the incidence of solid SMN after a first cancer in childhood. We studied a cohort of 4400 patients from eight centres in France and the UK. Patients had to be alive 3 years or more after a first cancer treated before the age of 17 years and before the end of 1985. For each patient in the cohort, the complete clinical, chemotherapy and radiotherapy history was recorded. For each patient who had received external radiotherapy, the dose of radiation received by 151 sites of the body were estimated. After a mean follow-up of 15 years, 113 children developed a solid SMN, compared to 12.3 expected from general population rates. A similar distribution pattern was observed among the 1045 patients treated with radiotherapy alone and the 2064 patients treated with radiotherapy plus chemotherapy; the relative risk, but not the excess absolute risk, of solid SMN decreased with time after first treatment; the excess absolute risk increased during a period of at least 30 years after the first cancer. This pattern remained after controlling for chemotherapy and for the average dose of radiation to the major sites of SMN. It also remained when excluding patients with a first cancer type or an associated syndrome known to predispose to SMN. When compared with radiotherapy alone, the addition of chemotherapy increases the risk of solid SMN after a first cancer in childhood, but does not significantly modify the variation of this risk during the time after the first cancer.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Andrieu, J. M., Ifarh, N., Payen, C., Fermanian, J., Coscas, Y. & Flandrin, G. (1990). Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin’s disease. J Clin Oncol 8: 1148–1154.
Bhatia, S., Robison, L. L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F. & Meadows, A. T. (1996). Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med 334: 745–751.
Blayney, D. W., Longo, D. L. & Young, R. C. and 5 others (1987). Decreased risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. N Engl J Med 316: 710
Breslow, N. E. & Day, N. E. (1987). Statistical Methods in Cancer Research. The Design and Analysis of Cohort Studies. International Agency for Research on Cancer: Lyon
Curtis, R., Boice, J. D. & Stovall, M. and 7 others (1992). Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326: 1745–1751.
de Vathaire, F., Shamsaldin, A. & Grimaud, E. and 26 others (1995). Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation. CR Acad Sci Paris 318: 483–490.
Diallo, I., Lamon, A., Shamsaldin, A., Grimaud, E., de Vathaire, F. & Chavaudra, J. (1996). Estimation of the radiation dose delivered at any point in the body for individual patient in external beam radiotherapy. Radiother Oncol 38: 269–278.
François, P., Beurtheret, C., Dutreix, A. & de Vathaire, F. (1988a). A mathematical child phantom for the calculation of dose to the organs at risk. Med Phys 15: 328–333.
François, P., Beurtheret, C. & Dutreix, A. (1988b). Calculation of the dose delivered to organs outside the radiation beams. Med Phys 15: 879–883.
Grimaud, E., Shamsaldin, A., Lamon, A., Hardiman, C., de Vathaire, F. & Chavaudra, J. (1994). Programme original de calcul de dose appliqué à l’étude de seconds cancers. Bull Cancer Radiother 81: 482
Hawkins, M. M., Draper, G. J. & Kingston, J. E. (1987). Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56: 339–347.
Hawkins, M. M., Kinnier Wilson, L. M., Stovall, M. A., Marsden, H. B., Potok, M. H. N., Kingston, J. E. & Chessells, J. M. (1992). Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer. Br Med J 304: 951–958.
Hawkins, M. M., Kinnier Wilson, L. M. & Burton, H. S. and 4 others (1996). Radiotherapy, alylating agents, and risk of bone cancer after a childhood cancer. J Natl Cancer Inst 88: 270–278.
Henry Amar, M. & Dietrich, P-Y (1993). Acute leukemia after the treatment of Hodgkin’s disease. Hematol Oncol Clin North Am 7: 368–387.
Kaldor, J. M., Day, N. E. & Clark, A. and 25 others (1990). Leukemia following Hodgkin’s disease. N Engl J Med 322: 7
Kellerer, A. M. & Barclay, D. (1992). Age dependencies in the modeling of radiation carcinogenesis. Radiat Prot Dosim 41: 273–281.
Little, M. P., Hawkins, M. M., Shore, R. E. & Hildreth, N. G. (1991). Time variations in the risk following irradiation in childhood. Radiat Res 126: 304–316.
Little, M. P., de Vathaire, F., Charles, M. W., Hawkins, M. M. & Muirhead, C. R. (1997). Variations with time and age in the relative risks of solid cancer incidence after radiation exposure. J Rad Prot 7: 159–177.
Moolgavkar, S. H. & Venzon, D. J. (1987). A method for computing profile likelihood based confidence bounds. Ann Statist 15: 346–359.
Olsen, J. H., Garwicz, S. & Hertz, H. and 8 others (1993). Second malignant neoplasm after cancer in childhood or adolescence. Br Med J 307: 1030–1036.
Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J. & Powel, J. (1992). Cancer Incidence in Five Continents, Vol VI. International Agency for Research on Cancer: Lyon
Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J. & Powel, J. (1993). Trends in Cancers Incidence and Mortality. International Agency for Research on Cancer: Lyon
Pierce, D. A., Vaeth, M. & Preston, D. (1991). Analysis of time and age patterns in cancer risk for A-bomb surivors. Radiat Res 127: 171–186.
Preston, D. L., Lubin, J. H. & Pierce, D. A. (1993). EPICURE User’s Guide. Hirosoft International Corporation: Seattle, WA
Sempé, M. (1979). Auxologie, méthodes et séquences. Theraplix: Paris
Shamsaldim, A., Grimaud, E., Hardiman, C., Diallo, I., de Vathaire, F. & Chavaudra, J. (1998). Dose distribution throughout the body for radiotherapy for Hodgkin’s disease in childhood. Radiother Oncol (in press)
Thompson, D. E., Mabuchi, K. & Ron, E. and 8 others (1994). Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958–1987. Radiat Res 137: 17–67.
Tokunaga, M., Land, C. E., Tokuoka, S., Nishimori, I., Soda, M. & Akiba, S. (1994). Incidence of breast cancer among atomic bomb suvivors, 1950–1985. Radiat Res 138: 209–223.
Tucker, M. A., Meadow, A. T., Boice, J. D., Hoover, R. N. & Fraumeni, J. F. (1984). Cancer risk following treatment of childhood cancer. In Radiation Carcinogenesis: Epidemiology and Biological Significance, Boice JD and Fraumeni JF (eds), p. 211. Raven Press; New York
Tucker, M. A., Meadow, A. T. & Boice, J. D. and 11 others (1987). Leukemia after therapy with alkylating agent for childhood cancer. J Natl Cancer Inst 78: 459–593.
Tucker, M. A., Morris-Jones, P. H. & Boice, J. D. and 10 others (1991). Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51: 2885–2888.
UNSCEAR (1994). Sources, Effects and Risks of Ionizing Radiation. United Nations: New York
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Vathaire, F., Hawkins, M., Campbell, S. et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 79, 1884–1893 (1999). https://doi.org/10.1038/sj.bjc.6690300
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690300
This article is cited by
-
Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
Cell & Bioscience (2022)
-
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan
International Journal of Clinical Oncology (2016)
-
Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case–control study
Radiation and Environmental Biophysics (2014)
-
Comparison of the dosimetries of 3-dimensions Radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma
BMC Medical Physics (2012)